BUSINESS Biotech Vets Launch VenBio for Both Private and Public Deals Biotech veterans from MPM Capital, OrbiMed Advisors, Pfizer Inc. and Morgan Stanley are out to transcend what they see as the limits of traditional life-sciences venture capital. [Wall Street Journal] European Medicines Agency Starts Formal Review of Glybera® Dossier Amsterdam Molecular Therapeutics (AMT) has reached another important milestone in the official marketing authorisation process for its lead product Glybera®, AMT’s proprietary product for lipoprotein lipase deficiency. [Amsterdam Molecular Therapeutics Press Release] American Medical Systems and Tissue Genesis Sign $1.1 Million Collaboration Deal Tissue Genesis, Inc. and American Medical Systems Holdings, Inc. announced that they have signed an agreement for the research and development of adipose (fat)–derived regenerative cells for use in treating pelvic health disorders. [Tissue Genesis, Inc. Press Release] International Stem Cell Corporation Progresses Towards Establishment of the Industry’s First Universal Stem Cell Bank, UniStemCellâ„¢ International Stem Cell Corporation announced that it has signed up the first two in vitro fertilization clinics and engaged an experienced pharmaceutical industry executive to lead the establishment of the company’s universal stem cell bank, UniStemCellâ„¢. [International Stem Cell Corporation Press Release] Geron Forms Collaboration to Investigate GRNOPC1 in Alzheimer's Disease Models Geron Corporation announced that it has entered into a collaboration jointly funded by Geron and a University of California Discovery Research and Training Grant to investigate the therapeutic potential of its human embryonic stem cell-based product, GRNOPC1, for Alzheimer's disease. [Geron Press Release] Geisinger Researchers Awarded Funds for Personalized Healthcare Project Researchers recently received funding totaling more than $44,000 from a Geisinger Health System – New York University Langone Medical Center collaborative project focusing on personalized healthcare. [Geisinger Medical Center Press Release] Roche Establishes New Medical Research Hub in Singapore Roche announced that it will enter into a strategic alliance with Singapore’s scientific and medical institutions to set up a major new translational research hub in Singapore. [Roche Press Release] UT-Battelle Licenses Tissue-Regeneration Technologies to NellOne Therapeutics; Advances Oak Ridge National Laboratory Spin-Out on Commercialization Path In a major step toward commercialization of a promising therapeutic treatment, Oak Ridge National Laboratory contractor UT-Battelle announced at a signing ceremony that it has exclusively licensed patents on inventions based on the Nell-1 gene to NellOne Therapeutics, Inc. [NellOne Therapeutics, Inc. Press Release] New Way to Grow Embryonic Stem Cells Holds Promise of Dramatic Reduction in Animal Use The winner of this year's annual NC3Rs 3Rs Prize has developed a new method of priming early embryos to form embryonic stem cells. [National Centre for the Replacement, Refinement and Reduction of Animals in Research Press Release] BioOhio Launches Scholarship Program To address financial needs and to promote bioscience career pursuits among Ohio’s students, BioOhio has launched the BioOhio Annual Scholarship program. [BioOhio Press Release] £5M Funding Partnership to Bring New Innovation and Economic Benefit to United Kingdom A £5M development at the Norwich Research Park, funded by a partnership including the Biotechnology and Biological Sciences Research Council will provide facilities for start-up and growing businesses that will turn world-class science into products and technologies. [Biotechnology and Biological Sciences Research Council Press Release] Limb Regeneration and Attosecond Research Each Get $1 Million from Keck Foundation Two University of California, Berkeley, research projects that push the boundaries of their fields have each received $1 million grants from the W.M. Keck Foundation. [University of California, Berkeley Press Release] T. Denny Sanford Donates $50 Million to Burnham Institute for Medical Research Burnham Institute for Medical Research announced that philanthropist T. Denny Sanford has pledged $50 million to support and further expand and accelerate the Institute’s leading-edge medical research. [Sanford-Burnham Institute for Medical Research Press Release] ReNeuron Regulatory Update ReNeuron Group plc provides a regulatory update regarding its ReN001 stem cell therapy for stroke. [ReNeuron Group plc Press Release] Neurologix Gains Broadened U.S. Patent Protection for Its Glutamic Acid Decarboxylase-Based Gene Delivery System Neurologix, Inc. announced that the U.S. Patent and Trademark Office has expanded the intellectual property protections enabled by a previously issued patent that is central to Neurologix's Parkinson's disease program. [Neurologix, Inc. Press Release] Financing Woes Delay Stem Cell Lab Construction A taxpayer-funded stem cell research laboratory planned for the Torrey Pines Mesa is among three such facilities in the works statewide that have hit snags in their construction timelines. [San Diego Business Journal] Coriell Cites Record of Innovation in Securing $27M National Institutes of Health Grant Coriell said the latest National Institutes of Health award, announced recently, will allow it to add “a powerful new type of stem cell,” called induced pluripotent stem cells to the human genetic cell repository of the National Institute of General Medical Sciences. [NJ Biz]
|